Pages that link to "Q33564338"
Jump to navigation
Jump to search
The following pages link to Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate (Q33564338):
Displaying 50 items.
- Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology (Q21129303) (← links)
- Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile (Q24625759) (← links)
- Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target? (Q26774957) (← links)
- Restoration of mitochondria function as a target for cancer therapy (Q26864167) (← links)
- Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking (Q27011482) (← links)
- Redox activation of metal-based prodrugs as a strategy for drug delivery (Q27025736) (← links)
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
- Metabolic modulation of glioblastoma with dichloroacetate (Q28282255) (← links)
- Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells (Q28834339) (← links)
- Polymeric Nanostructures for Imaging and Therapy (Q30372383) (← links)
- Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate (Q33662455) (← links)
- Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates (Q33808096) (← links)
- Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery (Q33825880) (← links)
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo (Q34550075) (← links)
- Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes (Q34731239) (← links)
- A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells (Q34948354) (← links)
- Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery (Q35000093) (← links)
- Lysosomal targeting with stable and sensitive fluorescent probes (Superior LysoProbes): applications for lysosome labeling and tracking during apoptosis (Q35165771) (← links)
- Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction. (Q35846798) (← links)
- Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells (Q35953911) (← links)
- Anticancer agents that counteract tumor glycolysis. (Q36452381) (← links)
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Q36635458) (← links)
- Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization (Q36734488) (← links)
- Higenamine Combined with [6]-Gingerol Suppresses Doxorubicin-Triggered Oxidative Stress and Apoptosis in Cardiomyocytes via Upregulation of PI3K/Akt Pathway (Q36943067) (← links)
- Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties (Q37042860) (← links)
- Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position (Q37087045) (← links)
- Two mixed-NH3/amine platinum (II) anticancer complexes featuring a dichloroacetate moiety in the leaving group (Q37101938) (← links)
- Metal-containing and related polymers for biomedical applications (Q37201391) (← links)
- Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate (Q37206708) (← links)
- Monofunctional and higher-valent platinum anticancer agents. (Q37282213) (← links)
- Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments (Q37437083) (← links)
- Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer (Q37612417) (← links)
- Synthetic methods for the preparation of platinum anticancer complexes (Q37722632) (← links)
- Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide (Q37735009) (← links)
- Targeting and delivery of platinum-based anticancer drugs (Q38050063) (← links)
- Metabolic modulation of cancer: a new frontier with great translational potential (Q38317294) (← links)
- The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents (Q38418672) (← links)
- Target-selective delivery and activation of platinum-based anticancer agents (Q38523600) (← links)
- Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer (Q38633157) (← links)
- A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines. (Q38696069) (← links)
- Platinum-based drugs: past, present and future (Q38737115) (← links)
- Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy (Q38762779) (← links)
- Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity. (Q38823861) (← links)
- Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy (Q38848959) (← links)
- Antitumor properties of platinum(iv) prodrug-loaded silk fibroin nanoparticles. (Q38896341) (← links)
- The Platin-X series: activation, targeting, and delivery. (Q38919253) (← links)
- Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity (Q38951818) (← links)
- An H₂O₂-responsive nanocarrier for dual-release of platinum anticancer drugs and O₂: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cells (Q38975894) (← links)
- Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. (Q38988403) (← links)
- Visible-light-induced annihilation of tumor cells with platinum-porphyrin conjugates (Q38992725) (← links)